Nephrology and Hypertension Associates, LTD

Tupelo, Mississippi 38801

1 studies enrolling now · 6 studies all time

What they study most

Anemia, End Stage Kidney Disease, Glomerulosclerosis, Focal Segmental, Hyperphosphatemia, Immunoglobulin A Nephropathy, Proteinuric Kidney Disease

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) — Running, not enrolling
• Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities — Running, not enrolling
• Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis — Completed
• A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis. — Completed
• Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy — Completed